HUT74091A - 1,5-benzodiazepine derivatives having cck and/or gastrin antagonistic activity - Google Patents
1,5-benzodiazepine derivatives having cck and/or gastrin antagonistic activity Download PDFInfo
- Publication number
- HUT74091A HUT74091A HU9502977A HU9502977A HUT74091A HU T74091 A HUT74091 A HU T74091A HU 9502977 A HU9502977 A HU 9502977A HU 9502977 A HU9502977 A HU 9502977A HU T74091 A HUT74091 A HU T74091A
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- phenyl
- compounds
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939307833A GB9307833D0 (en) | 1993-04-15 | 1993-04-15 | Modulators of cholecystokinin and gastrin |
| GB9406037A GB9406037D0 (en) | 1994-03-29 | 1994-03-29 | 1,5 Benzodiazepine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9502977D0 HU9502977D0 (en) | 1995-12-28 |
| HUT74091A true HUT74091A (en) | 1996-11-28 |
Family
ID=26302765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9502977A HUT74091A (en) | 1993-04-15 | 1994-04-13 | 1,5-benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0694040A1 (sk) |
| JP (1) | JPH08508743A (sk) |
| CN (1) | CN1120845A (sk) |
| AU (1) | AU688316B2 (sk) |
| CA (1) | CA2158972A1 (sk) |
| CZ (1) | CZ267695A3 (sk) |
| FI (1) | FI954852A (sk) |
| HU (1) | HUT74091A (sk) |
| NO (1) | NO954091L (sk) |
| NZ (1) | NZ265271A (sk) |
| OA (1) | OA10236A (sk) |
| PL (1) | PL311083A1 (sk) |
| SK (1) | SK125495A3 (sk) |
| WO (1) | WO1994024151A1 (sk) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE214056T1 (de) * | 1993-12-28 | 2002-03-15 | Shionogi & Co | Benzodiazepinderivate |
| ATE248823T1 (de) * | 1996-12-10 | 2003-09-15 | Zeria Pharm Co Ltd | 1,5-benzodiazepinderivate |
| US6444849B1 (en) | 1997-06-25 | 2002-09-03 | Mitsubishi Chemical Corporation | Amide derivatives |
| JP2000026434A (ja) | 1998-06-05 | 2000-01-25 | Zeria Pharmaceut Co Ltd | 新規１，５−ベンゾジアゼピン誘導体 |
| WO2000037434A1 (fr) * | 1998-12-22 | 2000-06-29 | Mitsubishi Chemical Corporation | Derives d'amide |
| GB201414116D0 (en) | 2014-08-08 | 2014-09-24 | Trio Medicines Ltd | Benzodiazepine derivatives |
| GB201513979D0 (en) | 2015-08-07 | 2015-09-23 | Trio Medicines Ltd | Synthesis of benzodiazepine derivatives |
| BR112022006546A2 (pt) | 2019-10-07 | 2022-08-30 | Kallyope Inc | Agonistas de gpr119 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2641280B1 (fr) * | 1988-12-29 | 1994-01-21 | Roussel Uclaf | Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments |
| FR2659653B1 (fr) * | 1990-03-13 | 1992-05-22 | Rhone Poulenc Sante | Derives de l'uree, leur preparation et les medicaments les contenant. |
| US5206234A (en) * | 1990-10-22 | 1993-04-27 | Merck & Co., Inc. | Benzolactam analogs as antagonists of cck |
| GB9201180D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
-
1994
- 1994-04-13 JP JP6522733A patent/JPH08508743A/ja active Pending
- 1994-04-13 NZ NZ265271A patent/NZ265271A/en unknown
- 1994-04-13 CZ CZ952676A patent/CZ267695A3/cs unknown
- 1994-04-13 SK SK1254-95A patent/SK125495A3/sk unknown
- 1994-04-13 PL PL94311083A patent/PL311083A1/xx unknown
- 1994-04-13 EP EP94913579A patent/EP0694040A1/en not_active Withdrawn
- 1994-04-13 AU AU65675/94A patent/AU688316B2/en not_active Ceased
- 1994-04-13 HU HU9502977A patent/HUT74091A/hu unknown
- 1994-04-13 CN CN94191771A patent/CN1120845A/zh active Pending
- 1994-04-13 CA CA002158972A patent/CA2158972A1/en not_active Abandoned
- 1994-04-13 WO PCT/EP1994/001130 patent/WO1994024151A1/en not_active Application Discontinuation
-
1995
- 1995-10-12 FI FI954852A patent/FI954852A/fi unknown
- 1995-10-13 NO NO954091A patent/NO954091L/no unknown
- 1995-10-21 OA OA60721A patent/OA10236A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994024151A1 (en) | 1994-10-27 |
| NO954091L (no) | 1995-12-13 |
| AU688316B2 (en) | 1998-03-12 |
| OA10236A (en) | 1997-10-07 |
| CA2158972A1 (en) | 1994-10-27 |
| FI954852A0 (fi) | 1995-10-12 |
| CZ267695A3 (en) | 1996-04-17 |
| FI954852A (fi) | 1995-10-12 |
| SK125495A3 (en) | 1996-06-05 |
| JPH08508743A (ja) | 1996-09-17 |
| EP0694040A1 (en) | 1996-01-31 |
| HU9502977D0 (en) | 1995-12-28 |
| CN1120845A (zh) | 1996-04-17 |
| AU6567594A (en) | 1994-11-08 |
| NZ265271A (en) | 1997-06-24 |
| PL311083A1 (en) | 1996-02-05 |
| NO954091D0 (no) | 1995-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5585376A (en) | 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity | |
| FI111632B (fi) | Menetelmä CCK-B-antagonistisesti vaikuttavien 1,5-bentsodiatsepiinijohdannaisten valmistamiseksi | |
| US5618812A (en) | Benzodiazepine derivatives | |
| US4820834A (en) | Benzodiazepine analogs | |
| US5004741A (en) | Methods of antagonizing CCK or gastrin with benzodiazepine analogs | |
| US20040024203A1 (en) | Benzodiazepine derivatives as inhibitors of gamma secretase | |
| IE904562A1 (en) | Benzodiazepine analogs for treating panic syndrome and for¹directly inducing analgesia | |
| BG99696A (bg) | Производни на 1,4-бензодиазепин,методи за тяхното получаване, съдържащи ги фармацевтични състави,използването им като сск- модулатори и метод за лечение на състояния,модулирани от сск | |
| US5521175A (en) | Benzodiazepine derivatives | |
| US6344452B1 (en) | 1,5-benzodiazepine derivatives | |
| US5686449A (en) | 1,5-benzodiazepines useful as gastrinor CCK-antagonists | |
| HUT74091A (en) | 1,5-benzodiazepine derivatives having cck and/or gastrin antagonistic activity | |
| HUT76135A (en) | Cholecystokinin and gastrin modulating 5-heterocyclic-1,5-benzodiazepines | |
| JPH0680650A (ja) | コレシストキニン拮抗薬 | |
| JP2004502677A (ja) | バソプレシン拮抗質としての非ペプチド系置換スピロベンゾアゼピン | |
| US5641775A (en) | 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists | |
| US5486514A (en) | Carbamate derivatives | |
| SI9300328A (sl) | Derivati 1,5-benzodiazepina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |